Keywords Real Time Quantitative PCR;chronic myelogenous leukemia;imatinib mesylate;BCR-ABL fusion gene;resistance mechanism;

• 实时定量PCR;慢性髓细胞白血病;伊马替尼;BCR-ABL融合基因;耐药机制;